Nature Index 2020 Cancer

Scientists are nudging the dial on some types of cancer more than others, but it’s fair to ask whether research is delivering value for money.

Vaccination is picking up where screening left off to reduce the incidence of one of the most common cancers in women.

The da Vinci robotic system has become the ubiquitous method for prostate removal, but its cost and long-term outcomes for patients are raising questions.

A transformative treatment is giving hope to some patients with metastatic skin cancers.

The search for disease mechanisms and treatments is one of the biggest collaborative efforts in science. These researchers are significant contributors.

A description of the terminology and methodology used in this supplement, and a guide to the functionality available free online at nature.com/nature-index/.

Integrating basic and clinical research, a new cancer institute established at Peking University welcomes cross-disciplinary researchers from around the world.

A stronger and more precise form of radiotherapy is poised to take a leading role in mainstream cancer therapy. It also provides options for those with previously untreatable cancers.

By integrating cancer research, treatment, prevention, and education, a specialized hospital in Tianjin is fulfilling its commitment to provide patients with the best care and medicine.

Keio University is leading one of Japan’s largest precision oncology projects using a new whole-exome sequencing platform.

Seoul National University’s preclinical research is rapidly translated into clinical trials, particularly in the field of therapeutic resistance.

Fundamental and translational research at the China Medical University in Taiwan reveals crucial insights for cancer mechanisms, informing the development of precision medicine.

Shizuoka Cancer Center and its surrounds are creating an advanced cancer treatment and care hub to maximize quality of life in line with longevity.

Emerging smart tools are helping prevent disease onset and progression. The medical informatics hub at Nagoya University is training specialists that will drive life-saving developments.

By harnessing genomic data and a multidisciplinary approach to cancer care, Asan Medical Center is forging ahead with individually tailored treatments, and it’s attracting international patients.

A conversation with PETER SHIELDS, MD, deputy director at The Ohio State University Comprehensive Cancer Center — Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James)

The Janssen Pharmaceutical Companies of Johnson & Johnson and the Lung Cancer Initiative at Johnson & Johnson are taking on the world’s most deadly cancer.

A young laboratory in Shenzhen aspires to be a world-class hub for biomedical and life sciences research to prevent and find effective solutions for major diseases, including cancer.